The United States Pharmacopeia (USP), along with co-sponsors AAPS and FIP, is hosting a three-day workshop on the technical and regulatory perspectives of nanomedicines. The meeting will be held March 20-22, 2017 in Rockville, MD. The draft agenda has been posted and includes global speakers from industry, academia, various government organizations. NCL’s Director Scott McNeil is slated to speak on day two of meeting and will discuss analytical challenges and advances in nanomedicine characterization.
For more information, please visit: http://www.usp.org/meetings-courses/workshops/nanomedicines-technical-and-regulatory-perspectives